Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Parenting on the margins: a qualitative study of the challenges encountered by fathers of children with autism in Limpopo Province, South Africa. [PDF]
Nkgaphela MR +3 more
europepmc +1 more source
Privatisation of Public Enterprises in Nigeria: Challenges and Prospects on Economic Development
Anthony Chukwuma Nwali +2 more
openalex +1 more source
Challenges of Providing Security in Lagos State: The case of Corporate Private Security Organisations [PDF]
Oluwakemi Omotoso, Adeyinka A. Aderinto
openalex +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Use Patterns and Challenges of the Social Media Platform X Among Physiotherapists in Saudi Arabia: Cross-Sectional Study. [PDF]
Alasfour M +6 more
europepmc +1 more source
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
When Policy Meets Reality: Municipal Leaders' Views Amid Rising LTC Expenditure. [PDF]
Tjerbo T, Hagen TP, Holte JH.
europepmc +1 more source
ATF4‐mediated stress response as a therapeutic vulnerability in chordoma
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone +11 more
wiley +1 more source

